Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Frenger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Allgemeinmedizin|July 31, 1970
[Rehabilitation of rheumatic patients]W Frenger
Die Medizinische Welt|November 12, 1982
[Heart condition and lung function in ankylosing spondylitis]G Strohmeyer, W Frenger
Arzneimittel-Forschung|December 1, 1973
[Efficacy and compatibility of bumadizone-Ca in rheumatoid diseases. A comparison with oxyphenbutazone]M Widhammer, W Frenger
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1983
[Lonazolac-Ca in rheumatic diseases. Studies on its therapeutic effectiveness]S Nobbe-Balogh, W Frenger
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
[Clinical trial with naproxen, with particular consideration to tolerance]W Frenger, H J Morbach
Die Medizinische Welt|November 7, 1975
[Multivariate analysis of metabolic disorders and of diseases associated with uricopathy]W Frenger, H J Morbach, V W Rahlfs
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Allgemeinmedizin|July 31, 1970
[Rehabilitation of rheumatic patients]W Frenger
Die Medizinische Welt|November 12, 1982
[Heart condition and lung function in ankylosing spondylitis]G Strohmeyer, W Frenger
Arzneimittel-Forschung|December 1, 1973
[Efficacy and compatibility of bumadizone-Ca in rheumatoid diseases. A comparison with oxyphenbutazone]M Widhammer, W Frenger
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1983
[Lonazolac-Ca in rheumatic diseases. Studies on its therapeutic effectiveness]S Nobbe-Balogh, W Frenger
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
[Clinical trial with naproxen, with particular consideration to tolerance]W Frenger, H J Morbach
Die Medizinische Welt|November 7, 1975
[Multivariate analysis of metabolic disorders and of diseases associated with uricopathy]W Frenger, H J Morbach, V W Rahlfs
Pageof 1